All News

Filament Health Announces Signing Of Definitive Agreement for Convertible Note Financing, Closing of C$900,000 Non-Brokered Private Placement Financing, Founder-Led Note Offering, And Other Updates Related To Proposed Business Combination

December 6, 2023 – Filament Health

VANCOUVER, BC — Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, is pleased to announce that, further to its press release dated November 23, 2023,… Read More

Member News

Mark Vineis Appointed as the New Country President of Novartis Canada

December 5, 2023 – Novartis Pharmaceuticals Canada Inc.

MONTREAL, QC — Novartis Canada announces that Mark Vineis has been appointed to the role of Country President, effective as of January 1, 2024. Mark brings a wealth of experience and… Read More

Member News

LifeLabs CISO Recognized as Top Global CISO in Cyber Defense Magazine Awards

December 5, 2023 – LifeLabs

TORONTO, ON — LifeLabs is excited to share that Mike Melo, Vice President of Technology Infrastructure & CISO, has been named the Top Global CISO for 2023 award at CyberDefenseCon 2023,… Read More

Member News

Improved X-rays and Bone Density Services Coming to Kamloops

December 5, 2023 – Interior Health

Residents in Kamloops and surrounding areas now have access to improved general X-ray and bone density testing services at the new Northills Centre Medical Imaging clinic at 42-700 Tranquille Rd. Formerly known… Read More

Member News

Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day

December 5, 2023 – Bausch Health

Bridgewater, N.J. — Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE/TSX: BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) announced they… Read More

Filament Health Announces Signing Of Definitive Agreement for Convertible Note Financing, Closing of C$900,000 Non-Brokered Private Placement Financing, Founder-Led Note Offering, And Other Updates Related To Proposed Business Combination

Mark Vineis Appointed as the New Country President of Novartis Canada

LifeLabs CISO Recognized as Top Global CISO in Cyber Defense Magazine Awards

Improved X-rays and Bone Density Services Coming to Kamloops

Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day

Category:

Sector:

Archives:

Filament Health Announces Signing Of Definitive Agreement for Convertible Note Financing, Closing of C$900,000 Non-Brokered Private Placement Financing, Founder-Led Note Offering, And Other Updates Related To Proposed Business Combination

Mark Vineis Appointed as the New Country President of Novartis Canada

LifeLabs CISO Recognized as Top Global CISO in Cyber Defense Magazine Awards

Improved X-rays and Bone Density Services Coming to Kamloops

Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day

Newsletter Signup